New drug combo aims to beat back relapsed leukemia
Disease control
Recruiting now
This study tests a new chemotherapy drug, L-Annamycin, combined with standard cytarabine in adults with acute myeloid leukemia (AML) that has come back or not responded to first treatment. About 312 participants will receive either the new drug combo or a placebo plus cytarabine.…
Phase: PHASE2, PHASE3 • Sponsor: Moleculin Biotech, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC